Universal Beteiligungs Und Servicegesellschaft Mb H Moon Lake Immunotherapeutics Transaction History

Universal Beteiligungs Und Servicegesellschaft Mb H

$56.8 Billion
Q3 2025

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	SELL	$32.84 - $51.05 $65,680 - $102,100	-2,000 Reduced 13.52%	12,790 $603,000
Q1 2025 May 06, 2025	SELL	$36.75 - $54.34 $196,649 - $290,773	-5,351 Reduced 26.57%	14,790 $577,000
Q4 2024 Feb 28, 2025	BUY	$45.84 - $57.91 $923,263 - $1.17 Million	20,141 New	20,141 $1.07 Million

Others Institutions Holding MLTX

# of Institutions

179

Shares Held

38.5M

Call Options Held

4.13M

Put Options Held

1.51M

Bvf Inc San Francisco, CA

19.8M
Shares

$252 Million
7.66% of portfolio
Avoro Capital Advisors LLC New York, NY

2M
Shares

$25.5 Million
0.2% of portfolio
Cormorant Asset Management, LP Boston, MA

1.99M
Shares

$25.5 Million
2.28% of portfolio
Balyasny Asset Management LLC Chicago, IL

1.7M
Shares

$21.7 Million
0.02% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

1.5M
Shares

$19.2 Million
0.02% of portfolio

View Full List

About MoonLake Immunotherapeutics

Ticker MLTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,925,600
Market Cap $472M
Description
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...

More about MLTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Universal Beteiligungs Und Servicegesellschaft Mb H, based on Form 13F filings with the SEC.

News

Stay updated on Universal Beteiligungs Und Servicegesellschaft Mb H with notifications on news.

Account